AnteoTech Ltd is pleased to provide a brief update on the COVID-19 Antigen Rapid Test (ART) development program.
20201224 AnteoTech Progresses COVID-19 Test Toward Market LaunchAnteoTech Ltd is pleased to provide a brief update on the COVID-19 Antigen Rapid Test (ART) development program.
20201224 AnteoTech Progresses COVID-19 Test Toward Market LaunchIf you have any general questions about our products or technology, contact customer support on (07) 3219 0085 or email contact@anteotech.com. For all technical support, please email support@anteotech.com.
For all investor-related queries please email investors@anteotech.com.